GSK’s plans to build new life science campus in UK moves a step closer after it secures project partners
If the hat fits: GSK boss Emma Walmsley
GSK’s plans to build a new life science campus in the UK moved a step closer after it secured project partners.
The asset management arm of Swiss investment bank UBS has linked up with London-based property developer Reef Group to create a joint venture that will construct the campus in Stevenage, ハートフォードシャー.
The venture will deliver £900m of investment for the site, which will be one of the largest of its kind in Europe.
The campus should create 5,000 new highly skilled jobs as part of chief executive Emma Walmsley’s plan to revitalise GSK’s credentials as a life science innovator.
GSK will sell 33 acres of land to develop the new campus, which is due to open in 2025.
It will be built next to GSK’s existing research and development hub in Stevenage.
‘The campus will add laboratory space and facilities for new companies to locate here,’ said Tony Wood, GSK’s chief scientific officer.